Rapid elimination of small stones from the middle third of the ureter: mechanisms of modulation of contraction and relaxation of smooth muscle tissue


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. evaluation of the molecular mechanisms that modulate the rapid elimination of small (<6 mm) stones in the middle third of the ureter. Material and methods. The prospective study included 2і patients with rapid (within 24-72 hours) elimination of stones from the middle third of the ureter against the background of standard lithokinetic therapy. Analysis of the functional activity of receptors that modulate ureteral motility was performed on a platelet suspension in vitro. the following agonists were used: atp, adp, adenosine, epinephrine, angiotensin-2 (Sigma-Aldrich Chemie Gmbh, Germany). platelet aggregation was assessed by the turbidimetric method on a ChronoLog analyzer (usa). results. During the elimination of stones in the first 24 hours of lithokinetic therapy, hyperreactivity of the α2-adrenergic, angiotensin ati, purine P2Y and P2X1 receptors was revealed. this fact confirms the possibility of enhancing the contractile activity of the ureter through the sympathetic-adrenal (sas) and renin-angiotensin systems (ras), as well as the local myogenic mechanism associated with an increase in the extracellular adp level. delayed for 48-72 hour elimination of stones was characterized by modulation of ureteral motility through the α2-adrenoreceptor due to activation of the cas and the atp-induced purine P2X1 receptor. the revealed P2X1 receptor hyperreactivity may be associated with the need to increase the force of contraction of the smooth muscle tissue of the ureter in conditions of limited ras activity and persistent urinary tract ischemia. a necessary condition for the elimination of small stones was the maintenance of the basal level of relaxation of the ureteral muscularis which was achieved by maintaining the adenosine A2A receptor normoreactivity. Conclusion. The variability in the timing of rapid elimination of small stones during lithokinetic therapy is determined by the individual characteristics of the formation and regulation of compensatory mechanisms in the process of nephrolithiasis, the purpose of which is to optimize the processes of contraction and relaxation of the ureteral muscularis.

Full Text

Restricted Access

About the authors

Eduard F. Barinov

M. Gorky Donetsk National Medical University

Email: barinov.ef@gmail.com
Dr.Sci. (Med.), Professor, Head of the Department of Histology, Cytology and Embryology Donetsk, Donetsk People's Republic

Yury Yu. Malinin

M. Gorky Donetsk National Medical University

Email: jora2@list.ru
Cand. Sci. (Med.), Head of the Department of Urology Donetsk, Donetsk People's Republic

Khachen V. Grigoryan

M. Gorky Donetsk National Medical University

Email: khachengrigoryan@gmail.com
Cand. Sci. (Med.), Teaching Assistant at the Department of Urology Donetsk, Donetsk People's Republic

References

  1. Liu J., Zhao M., Chen Z., et al. TRPM3 channel activation inhibits contraction of the isolated human ureter via CGRP released from sensory nerves. Life Sci. 2021;268:118967. doi: 10.1016/j.lfs.2020.118967.
  2. Morsy S., Nasser I., Aboulela W., et al. Efficacy of Mirabegron as Medical Expulsive Therapy for Distal Ureteral Stones: A Prospective, Randomized, Double-Blinded, Controlled Study. Urol/ Int. 2022;31:1-7. doi: 10.1159/000521171.
  3. Osman F., Romics I., Nyirady P., et al. Ureteral motility. Acta Physiol Hung. 2009;96(4):407-26. doi: 10.1556/APhysiol.96.2009.4.2.
  4. Matsumoto R., Otsuka A., Suzuki T., et al. Expression and functional role of ß3 -adrenoceptors in the human ureter.Int. J. Urol. 2013;20(10):1007-14. doi: 10.1111/iju.12093.
  5. Shen H., Chen Z., Mokhtar A.D., et al. Expression of ß-adrenergic receptor subtypes in human normal and dilated ureter.Int. Urol. Nephrol. 2017;49(10):1771-78. doi: 10.1007/s11255-017-1667-y.
  6. Guan N.N., Gustafsson E., Svennersten K. Inhibitory Effects of Urothelium-related Factors. Basic Clin. Pharmacol. Toxicol. 2017;121(4):220-24. doi: 10.1111/bcpt.12785.
  7. Figueroa S.M., Lozano M., Lobos C., et al. Upregulation of Cortical Renin and Downregulation of Medullary (Pro)Renin Receptor in Unilateral Ureteral Obstruction. Front. Pharmacol. 2019;10:1314. doi: 10.3389/fphar.2019.01314.
  8. Harrison P., Mackie I., Mumford A. British. Guidelines for the laboratory investigation of heritable disorders of platelet function. Brit. J. Haematol. 2011;155(1):30-44. doi: 10.1111/j.1365-2141.2011.08793.x.
  9. Al-Sofiani M.E., Yanek L.R., Faraday N., еt al. Diabetes and Platelet Response to Low-Dose Aspirin. J. Clin. Endocrinol. Metab. 2018;103(12):4599-608. doi: 10.1210/jc.2018-01254.
  10. Yu W., Hill W.G., Robson S.C., Zeidel M.L. Role of P2X4 Receptor in Mouse Voiding Function. Sci. Rep. 2018;8(1):1838. doi: 10.1038/s41598-018-2021.
  11. Monks D.R., BRund S.J. The modulation of ureteral smooth muscle contractile responses by a1- and a2-adrenoceptor activation. Physiol Int. 2018;105(3):225-32. doi: 10.1556/2060.105.2018.3.19.
  12. Comiter C. Local renin-angiotensin systems in the genitourinary tract. Naunyn Schmiedebergs Arch. Pharmacol. 2012;385(1):13-26. doi: 10.1007/s00210-011-0706-y.
  13. Mastropaolo M., Zizzo M.G., Auteri M., et al. Activation of angiotensin II type 1 receptors and contractile activity in human sigmoid colon in vitro. Acta Physiol. (Oxf). 2015;215(1):37-45. doi: 10.1111/apha.12538.
  14. Aschrafi A., Berndt A., Kowalak J.A., et al. Angiotensin IImediates the axonal trafficking of tyrosine hydroxylase and dopamine ß-hydroxylase mRNAs and enhances norepinephrine synthesis in primary sympathetic neurons. J. Neurochem. 2019;150(6):666-77. doi: 10.1111/jnc.14821.
  15. Hao Y., Wang L., Chen H., et al. Targetable purinergic receptors P2Y12 and A2b antagonistically regulate bladder function. JCI Insight. 2019;4(16):e122112. doi: 10.1172/jci.insight.122112.
  16. Yu W., Sun X., Robson S.C., Hill W.G. ADP-induced bladder contractility is mediated by P2Y12 receptor and temporally regulated by ectonucleotidases and adenosine signaling. FASEB J. 2014;28(12):5288-98. doi: 10.1096/fj.14-255885.
  17. Kishore B.K., Robson S.C., Dwyer K.M. CD39-adenosinergic axis in renal pathophysiology and therapeutics. Purinergic Signal. 2018;14(2):109-20. doi: 10.1007/s11302-017-9596-x.
  18. Yu W., Hill W.G., Robson S.C., Zeidel M.L. Role of P2X4 Receptor in Mouse Voiding Function. Sci. Rep. 2018;8(1):1838. doi: 10.1038/s41598-018-20216-4.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies